The debate surrounding adult stem cell plasticity derives from a confusion regarding definitions of important terms and the identification of key questions. After defining plasticity, lineage, differentiation and transdifferentiation, the authors put forth a framework for future dialogue as well as their perspective on the stem cell plasticity debate.
Introduction
The debate over adult bone marrow stem cell plasticity has reached a feverish pitch in recent months in the wake of several reports indicating that these cells have the capacity to differentiate into nonhematopoietic cells. Although debate invigorates the field, it can be destructive if it degenerates into a confusion over semantics. In an attempt to clarify the key issues surrounding adult bone marrow stem cell plasticity, we will present seven central questions that need to be addressed at the outset of a productive discussion of the plasticity issue.
Before any debate can proceed, the participants must agree on definitions of the key terms (see Figure 1) . Unfortunately, many investigators have made use of these terms haphazardly in describing their results, muddying the comparison with other studies. We propose the following definitions for terms that have been variously defined by a variety of investigators. We believe that the following definitions provide a precise standard that should be adopted by all stem cell investigators:
Plasticity is a general term denoting the capacity of a cell to convert from one type to another. Use of this term implies nothing with respect to the maturity of the cells involved.
Lineage is defined as descending from a common ancestor cell. Since the entire organism derives from a single ancestor cell (the fertilized ovum), the term 'lineage' becomes meaningful only when the ancestor cell is clearly identified.
Differentiation is the process whereby a cell proceeds from a potential state toward adult form and function. This term implies a purely vertical progression from a more primitive to a less primitive condition wherein conversion from one cell lineage to another does not take place.
Transdifferentiation is the process whereby a cell of a particular lineage converts to that of another. Like 'plasticity', use of this term implies nothing with regard to the maturity of either the originating or the resulting cell. However, the term does imply a horizontal movement across lineage boundaries. Now that we have established definitional standards, we will address the key questions that must be addressed in a constructive debate regarding the plasticity of adult bone marrow stem cells:
Is transdifferentiation even possible?
Although some investigators question the very existence of transdifferentiation, nature provides dramatic examples of transdifferentiation across germinal layer boundaries in the form of tumor metaplasia ( Figure 2 ). Yañ ez-Mó et al 1 recently demonstrated that the inflammatory injury intrinsic to peritoneal dialysis elicits an epithelial-to-mesenchymal transdifferentiation of peritoneal mesothelial cells. Finally, Barrett's esophagus, in which there is a conversion from squamous to columnar cells in response to chronic gastric acid reflux, is a common example of physiologic conversion within germinal layer boundaries. However, it must be acknowledged that it is virtually impossible to rule out the possibility that the transdifferentiated cells derive from a rare uncommitted stem cell already located within the tissue. Theise and Krause, 2 previously in this journal, discuss in detail the mechanism by which transdifferentiation might occur.
Is the new cell what you say it is?
If a bone marrow-derived donor stem cell takes on a morphological and antigenic phenotype consistent with, for instance, a hepatocyte, then is the new cell in fact a hepatocyte? If a donor cell has the same polygonal shape as the adjacent host hepatocytes and expresses albumin as detected by immunohistochemistry, can we therefore conclude that it is indeed a hepatocyte? Antiplasticity proponents make legitimate arguments that a donor cell sitting among hepatocytes may imbibe albumen from its surroundings and be shaped by its abutting neighbors to take on the appearance of a hepatocyte, but still retain its essential hematopoietic nature and not fulfill all of the duties of a resident hepatocyte. Until investigators can agree on a standard of identity for each cell type, debate about the legitimacy of differentiation will persist. We propose that, as a minimum for publication, a cell can be considered differentiated if it takes on the morphological characteristics as well at least one of the established antigenic markers of the host cells. Further, this antigenic expression must be demonstrated by three-dimensional imaging in order to establish that the phenotype of overlapping resident cells is not masking a hematopoietic donor cell. A demonstration of functionality would also be helpful in defining true plasticity. There have been several dramatic studies showing that purified murine stem cells can produce hepatocytes 3 and cardiac myocytes 4 in a mouse genetic liver disease and with myocardial ischemia, respectively. In these settings, liver and cardiac function was improved and mortality decreased. This is clear proof in principle that marrow stem cells can produce functioning cells of nonhematopoietic tissues. In some cases mere form demonstrates function, as in the case of an osteocyte sitting within a bony lacuna. In other settings, expression of cell-specific proteins represents an inherent measure of cellular function, as in an albumen stain of hepatocytes. The demand for function on a tissue or organ level for each study is simply premature. This is in fact the goal of most investigators; and it is a difficult but achievable goal. The application of these approaches to clinical settings will take a good deal of specific study for each diseased organ or tissue. While obtaining functional effects on a tissue or organ level is the end point; it should not be raised as a limiting criticism of the field.
Is the differentiation robust enough to make a difference?
In a recently reported study by Wagers et al 5 only one donorderived neuron could be identified after examination of more than 13 million brain cells in 60 histologic sections of a mouse brain that had not undergone experimental injury. The authors reported this as a negative finding. But that single cell -a large, arborizing Purkinje neuron -had an unquestionable neuronal phenotype. The rarity of the phenomenon is notable, but the existence of the phenomenon cannot be discounted. We would argue that these sometimes rare instances of differentiation are the exception that proves the rule that nonhematopoietic differentiation is possible given the proper microenvironmental circumstances. Rather than dismissing this lone neuron as a fluke, we need to explore what factors allowed such an extraordinary cell to come into existence. 'Robustness' is, after all, a relative term. As a first step in plasticity studies, 0.001% of cells showing transdifferentiation can be considered 'robust'. Perhaps 0.1% of cells being malignant melanoma cells in a lung can be considered 'robust' in terms of clinical relevance. For purposes of gene therapy, 3-5% converted donor cells may be robust in terms of bringing about clinical improvement. And for restoration of whole-organ function, 30-40% of cells may be required to convert or 'transdifferentiate' before the term 'robust' can be applied. Therefore, in the plasticity debate, the call for robustness is not meaningful and should be dropped from the debate. 
Does cell fusion count as plasticity?
The discovery that adult stem cells can merge with embryonic stem cells in vitro has led some investigators to hold that stem cell plasticity is a random fusion phenomenon. 6 But as Helen Blau 7 writes in a recent commentary in Nature, rather than seeing fusion as merely an unimportant, random occurrence, it may represent the mechanism whereby nomadic stem cells initiate differentiation and repair in damaged tissues.
Does transdifferentiation depend on appropriate injury?
It is evident that tissue injury is a necessary background for robust differentiation and functional repair. Again, Barrett's esophagus provides a dramatic physiological example of injury causing transdifferentiation. Simply infusing cells into a healthy, uninjured animal is not likely to elicit a signal for homing and repair by circulating stem cells. Not only injury, but a stem cell attracting and stem cell correctable injury, must be present to call forth bone marrow stem cell repair. The nature and degree of injury to promote optimum marrow conversion to nonhematopoietic cells will be different for each tissue. For instance, we have found, studying marrow homing to brain, that homing increases from 0 to 1000 cGy whole-brain irradiation, but decreases at 2000 cGy. Thus, the ideal injury probably combines the generation of appropriate chemokine signals, the expression of specific adhesion proteins, and the depletion of tissue -endogenous stem cells. With this in mind, if a study is described as a negative refutation of a previous positive one, it must exactly reproduce the injury of the postive study in order to be legitimately called 'negative'. For example, the 'negative' study by Castro et al, 8 which involved irradiation and mechanical injury to the murine cerebral cortex, failed to reproduce the injuries reported in four other positive studies (Table 1) , and thus cannot be used to refute those studies. Therefore, we stress that finding the proper injury in each tissue model is necessary to establish the proper milieu to maximize stem cell differentiation and functional repair.
Must tissue repopulation be clonally derived?
Some investigators contend that in order to unequivocally establish transdifferentiation, a single somatic stem cell must be shown to give rise to both the 'expected' tissue and the 'unexpected' tissue. 'It was just such an emphasis on clonal analysis that led to the establishment of the basic properties of stem cells in the mid-1960's,' writes Ihor Lemischka 9 of Princeton. 'That is, it was clearly shown that a single stem cell can both self-renew and give rise to robust populations of different blood cell types.' However, in light of increasing evidence that the hierarchical hematopoietic stem cell theory may be inaccurate, 10 this reasoning appears flawed by a faulty initial assumption. We agree that studies which begin with a single stem cell will likely yield results different from those which begin with a population of cells. However, population studies are more significant as they more accurately reflect the physiologic reality of continuously interacting cells.
The priniciple theoretical problem with performing single-cell clonal experiments is that the investigator is making an a priori assumption that a particular set of phenotypic markers defines a stem cell. Once this is done, the population has been defined and if it acts in a certain fashion, then stem cells act in that fashion. Subsetting to a single or a few cells makes no sense in this context. In addition to this theoretical difficulty, there is a practical problem here as well: even the most purified stem cell population is heterogeneous. In our own studies, a 'pure' population of lineage-negative, rhodamine-low, Hoechst-low cells is nevertheless intrinsically heterogeneous. For instance, only a subfraction of these cells will form single-cell clones in the presence of interleukin-3, -6, -11 and steel factor. In morphologic studies determining blast cell, eosinophil, basophil, neutrophil, macrophage, monocyte, lymphocyte, plasma cell, megakaryocyte and mitotic cell content of these clones, 14 different colony types were identified. And with passage through cell cycle, the phenotype of these cells continuously changed. These observations indicate that the study of one or a few clones from a stem cell population, while providing information of interest, will always be misleading. In order to fully characterize a population, many clones must be studied. This, of course, is a population study, which is far more meaningful in defining a population than is a clonal study of a cell derived from that population.
Cell population studies are not hindered by the same artificial conditions that limit single-cell clonal studies. Population studies account for multiple cells acting in synchrony to achieve transdifferentiation, providing cytokine support or other intercellular signaling for one another. In addition, population studies allow for the possibility that each individual stem cell possesses a reversible, fluctuating phenotype with transient plastic potential, as studies by our group have suggested. In this scenario, any particular stem cell has only a statistically probable chance of having plastic potential, necessitating the isolation of a population of cells to have statistical assurance that a potentially plastic stem cell is present.
Thus, while single-cell and cell population studies provide useful information about heterogeneity, population studies are necessary in order to characterize stem cell plasticity.
Finally, why are there so many negative plasticity studies that seem to contradict the positive ones?
Apart from differences in interpretation, as noted above in the discussion of what constitutes robust transdifferentiation, a careful reading of the methodology sections of these reports reveals that the negative studies in no way reproduce the conditions of the positive studies. Table 1 shows the wide variations among the principle studies investigating hematopoietic to neural stem cell transdifferentiation in adults with respect to cell population infused, means of delivery, fixation technique, method of analysis, and so on. This is a situation in which the devil truly is in the details. Each of these methodological differences is a variable that can account for the disparate results obtained by various research teams. Faithful reproduction of studies by multiple groups would help to tease out the variables that allow for plasticity to occur.
Sir Francis Bacon, in Novum Organum (1620), wrote that men are prone toward adopting convenient mental representations, or 'idols', that arise from established dogmas of philosophy. The distinct developmental divisions of cells and the hierarchical differentiation schema to which they are subject may be one such 'idol of the mind. ' Bacon 11 writes that 'the human understanding is of its own nature prone to suppose the existence of more order and regularity in the world than it finds.' Investigators should be cognizant of such idols when observing cell transformations, keeping in mind that negative studies need to be carried out with the same scientific rigor urged for positive studies. Once the optimal conditions for adult bone marrow stem cell plasticity are established, the next challenge will be to identify the microenvironmental cues that Table 1 In vivo studies of hematopoietic to neural cell conversion in adults BM -bone marrow; BMT -bone marrow transplant; CREB -cAMP response element-binding protein; FISH -fluorescent in situ hybridization; GFP -green fluorescent protein; IL -interleukin; IV -intravenous; ISHH -in situ hybridization histochemistry; MCA -middle cerebral artery; MSCmesenchymal stem cells; neo R -neomycin resistant; OB -olfactory bulb; PFH -paraformaldehyde; pBMT -post-bone marrow transplant; p-injury -postinjury; SCF -stem cell factor; SHR -spontaneously hypertensive rats; SP -side population; WBM -whole bone marrow.
